分子诊断市场－全球产业规模、份额、趋势、机会和预测，按产品和服务、技术、应用、最终用户、地区和竞争细分，2020-2030 年

2024年，全球分子诊断市场规模达176.5亿美元，预计2030年将达267亿美元，复合年增长率为7.10%。分子诊断涵盖了用于分析与多种人类疾病相关的生物标记物的技术。这些诊断测试在完善的医疗保健系统中至关重要。透过提供关键讯息，分子诊断可以帮助医护人员和患者做出明智的医疗决策，从而获得成功的结果。此外，分子诊断提供的定量测量有助于进行全面的护理管理，并有效控制各种健康状况。

在临床环境中，分子诊断工具已被证明是有益的，因为它能够实现快速灵敏的检测方法，有助于监测各种传染病，包括癌症和其他慢性疾病。透过广泛应用分子诊断，基因检测、微生物学、性传染病、肿瘤学、血液筛检、病毒学、组织分型和产前诊断等疾病都已成功检测出来。实验室分子诊断透过分析DNA、RNA或蛋白质，是人类疾病辨识不可或缺的工具。专为分子诊断设计的试剂和试剂盒因预期应用而异，其探针针对特定的病毒、细菌和寄生虫序列。生物标记特异性检测试剂盒的使用率不断提高，有望推动分子诊断市场的成长，因为这些检测在开始任何疗法或治疗之前都具有极高的价值。

关键市场驱动因素

慢性病盛行率上升

主要市场挑战

分子诊断成本高昂

主要市场趋势

对即时诊断的需求不断增长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：分子诊断市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品和服务（试剂和试剂盒、仪器、服务和软体）
  • 按技术（聚合酶炼式反应 (PCR)、定序、原位杂交、晶片和微阵列、质谱、其他）
  • 按应用（传染病、肿瘤检测、基因检测、血液筛检、其他）
  • 按最终用户（医院、学术和参考实验室、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美分子诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲分子诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太分子诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲分子诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲分子诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球分子诊断市场：SWOT 分析

第 14 章：竞争格局

• F Hoffmann-la Roche Ltd
• Illumina Ltd
• Hologic Corporation
• Agilent Technologies Inc.
• Qiagen NV
• Grifols SA
• Becton, Dickinson and Company
• Abbott Laboratories, Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• Sysmex Corporation

第 15 章：策略建议

第16章调查会社について・免责事项

Global Molecular Diagnostics market was valued at USD 17.65 Billion in 2024 and is expected to reach USD 26.70 Billion by 2030 with a CAGR of 7.10%. Molecular diagnostics, as a term, encompasses techniques utilized for the analysis of biological markers implicated in a broad spectrum of human diseases. These diagnostic tests hold pivotal significance within a well-established healthcare system. By providing crucial information, molecular diagnostics aid healthcare providers and patients in making informed medical decisions, resulting in successful outcomes. Moreover, the quantitative measurements offered by molecular diagnostics facilitate comprehensive care management and effective control of various health conditions.

In the clinical setting, molecular diagnostics tools have proven to be beneficial by enabling rapid and sensitive detection methods, thereby facilitating monitoring of a wide array of infectious diseases, including cancers and other chronic illnesses. Genetic testing, microbiology, STDs, oncology, blood screening, virology, tissue typing, and prenatal diagnostics are among the medical conditions successfully detected through the extensive application of molecular diagnostics. Laboratory-based molecular diagnostics serve as indispensable tools for disease identification in humans, employing the analysis of DNA, RNA, or proteins. Reagents and kits specifically designed for molecular diagnostics vary depending on the intended application, with probes targeting specific viral, bacterial, and parasitic sequences. The increasing utilization of biomarker-specific testing kits is poised to drive the growth of the Molecular Diagnostics Market, as these tests prove invaluable prior to the initiation of any therapy or treatment.

Key Market Drivers

Boosting Prevalence of Chronic Ailments

Due to the rapid mechanization of various industries, the concept of manual work has gradually diminished from people's daily lives. As a result, sedentary lifestyles and poor dietary habits have become prevalent, leading to an alarming increase in needle-stick diseases like cancer. According to estimates by the World Health Organization (WHO), cancer was responsible for approximately 10 million deaths globally in 2021, accounting for nearly one in every six fatalities. This positions cancer as one of the most significant causes of mortality worldwide, underscoring its critical impact on global public health. Of these cases.

Furthermore, the rise in infectious diseases and other communicable ailments has contributed to the growing demand for molecular diagnostics. Conditions such as kidney disease, respiratory infections, and chronic obstructive pulmonary disease have become all too common. According to the National Kidney Foundation, approximately 37 million adults in the United States were living with chronic kidney disease (CKD) as of late 2020. This figure highlights CKD as a major public health concern, reflecting its widespread prevalence and growing burden on the U.S. healthcare system. The prevalence of chronic kidney disease (CKD) is expected to rise to epidemic levels, driven largely by the rapid aging of the global population. CKD represents a critical global health challenge, with its increasing incidence posing significant concerns particularly for low- and middle-income countries where healthcare resources are often limited.

The implications of these health challenges are far-reaching, affecting individuals, families, and communities worldwide. It is crucial for medical professionals, researchers, and policymakers to focus on preventive measures, early detection, and effective treatment strategies to mitigate the impact of these diseases and improve overall public health.

Key Market Challenges

High Cost of Molecular Diagnostics

Although immensely useful, molecular diagnostics do have some restrictions and drawbacks. One of the main limitations is the higher cost compared to more established conventional methods. The expenses involved in molecular diagnostics include not only the cost of equipment and supplies but also the need for highly specialized personnel and maintenance. These factors can make it financially prohibitive for some labs, especially those with limited resources. However, it is important to note that as molecular techniques become more widespread and adopted by a larger number of labs, the costs are expected to decrease. This is due to economies of scale and advancements in technology that can lead to more affordable equipment and reagents. As a result, labs that currently find the cost of molecular diagnostics prohibitive may choose to outsource their molecular specimens to external reference labs.

Despite these challenges, the field of molecular diagnostics continues to show great potential and has already made significant contributions to healthcare. It is anticipated that as the costs decrease and the technology becomes more accessible, the market for molecular diagnostics will expand further, benefiting patients and healthcare providers alike.

Key Market Trends

Increasing Demand for Point-of-Care Diagnostics

The increasing demand for point-of-care (POC) diagnostics has significantly driven the demand for molecular diagnostics, reshaping the landscape of medical testing and healthcare delivery. Several key factors contribute to this growing trend. POC diagnostics offer the advantage of delivering rapid and accurate test results at or near the patient's location, often within minutes. This immediacy is critical in emergency situations, for monitoring chronic diseases, or when making time-sensitive treatment decisions. Molecular diagnostics, with its precision and sensitivity, plays a pivotal role in POC testing by enabling the detection of specific genetic material or biomarkers associated with various diseases, including infectious diseases, cancer, and genetic disorders.

Additionally, as healthcare systems strive to improve patient outcomes while reducing costs, the shift towards decentralized testing at the POC has gained momentum. Molecular diagnostics offers the capability to identify diseases at earlier stages, aiding in personalized treatment plans and ultimately reducing the burden of advanced disease cases and hospitalizations. The evolving landscape of telemedicine and remote healthcare delivery also plays a role in driving the demand for molecular diagnostics at the point of care. Patients in remote or underserved areas can benefit from POC molecular tests that provide timely insights into their health conditions, enabling healthcare providers to make informed decisions and recommendations from afar.

Key Market Players

• F Hoffmann-la Roche Ltd
• Illumina Ltd
• Hologic Corporation
• Agilent Technologies Inc.
• Qiagen NV
• Grifols S.A.
• Becton, Dickinson and Company
• Abbott Laboratories, Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• Sysmex Corporation

Report Scope:

In this report, the Global Molecular Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Diagnostics Market, By Products and Services:

• Reagents and Kits
• Instruments
• Services & Software

Molecular Diagnostics Market, By Technology:

• Polymerase Chain Reaction (PCR)
• Sequencing
• In-situ hybridization
• Chips and microarrays
• Mass spectrometry
• Others

Molecular Diagnostics Market, By Application:

• Infectious disease
• Oncology testing
• Genetic testing
• Blood screening
• Others

Molecular Diagnostics Market, By End User:

• Hospitals
• Academic & Reference Laboratories
• Others

Molecular Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Diagnostics Market.

Available Customizations:

Global Molecular Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Molecular Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products and Services (Reagents and Kits, Instruments, Services & Software)
  • 5.2.2. By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others)
  • 5.2.3. By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others)
  • 5.2.4. By End User (Hospitals, Academic & Reference Laboratories, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Molecular Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products and Services
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products and Services
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Molecular Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products and Services
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Molecular Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products and Services
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Molecular Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products and Services
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products and Services
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Molecular Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products and Services
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Molecular Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products and Services
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Molecular Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products and Services
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Molecular Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products and Services
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Molecular Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products and Services
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Molecular Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products and Services
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Molecular Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products and Services
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Molecular Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products and Services
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Molecular Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products and Services
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Molecular Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products and Services
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Molecular Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products and Services
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Molecular Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products and Services
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Molecular Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products and Services
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Molecular Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products and Services
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Molecular Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products and Services
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Molecular Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products and Services
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Molecular Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products and Services
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Molecular Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products and Services
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Molecular Diagnostics Market: SWOT Analysis

14. Competitive Landscape

• 14.1. F Hoffmann-la Roche Ltd
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Illumina Ltd
• 14.3. Hologic Corporation
• 14.4. Agilent Technologies Inc.
• 14.5. Qiagen NV
• 14.6. Grifols S.A.
• 14.7. Becton, Dickinson and Company
• 14.8. Abbott Laboratories, Inc.
• 14.9. Biomerieux SA
• 14.10.Bio-Rad Laboratories Inc.
• 14.11.Sysmex Corporation

15. Strategic Recommendations

16. About Us & Disclaimer